Actinogen Medical (ASX:ACW) FCF Margin %: 0.00% (As of Dec. 2025)


What is Actinogen Medical FCF Margin %?

Actinogen Medical ASX:ACW +1.52% FCF Margin % is 0.00% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Actinogen Medical ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Actinogen Medical's Free Cash Flow for the six months ended in Dec. 2025 was A$-7.12 Mil. Actinogen Medical's Revenue for the six months ended in Dec. 2025 was A$0.00 Mil. Therefore, Actinogen Medical's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Actinogen Medical's current FCF Yield % is -13.42%.

The historical rank and industry rank for Actinogen Medical's FCF Margin % or its related term are showing as below:


ASX:ACW's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Actinogen Medical FCF Margin % Related Terms

Actinogen Medical FCF Margin % Historical Data

* Premium members only.

The historical data trend for Actinogen Medical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Actinogen Medical FCF Margin % Chart

Actinogen Medical Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Actinogen Medical Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASX:ACW vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Actinogen Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actinogen Medical FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinogen Medical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Actinogen Medical's FCF Margin % falls into.


Actinogen Medical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Actinogen Medical's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-7.594/0
= %

Actinogen Medical's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-7.121/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Actinogen Medical (ASX:ACW) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Actinogen Medical and its competitors. According to the industry distribution chart, Actinogen Medical ranks #999999 out of 959 companies in the Biotechnology industry.
Is Actinogen Medical's FCF Margin % too high?
Actinogen Medical's current FCF Margin % is 0.00%. Based on the distribution chart, Actinogen Medical ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Actinogen Medical's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Actinogen Medical ranks #999999 out of 959 companies for FCF Margin %. This places Actinogen Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Actinogen Medical and its competitors. Actinogen Medical's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Actinogen Medical stock overvalued right now?
Actinogen Medical (ASX:ACW) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Actinogen Medical (ASX:ACW), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Actinogen Medical Business Description

Other Exchanges ATGGF:USA3AC:Germany
Address 109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Actinogen Medical Ltd is a biotechnology company. The company develops a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated cortisol in the brain. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.